Logo Image
|Articles|October 27, 2014

ACRO Creates CRO Forum to Liaise with TransCelerate BioPharma

ACRO announced its plans to establish a CRO Forum

The Association of Clinical Research Organizations (ACRO) announced its plans to establish a CRO Forum to provide a formal mechanism for the CRO industry to furnish input into the work of TransCelerate BioPharma. The CRO Forum is expected to commence in January 2015 and is open to all CROs. Participation is included as a benefit of ACRO membership. The CRO Forum will provide subject matter experts from its participants as liaisons to relevant TransCelerate workstreams.

Read the full release here.

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more